PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Leader Biomedical

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

EMCM Contributes to Renal Cancer Treatment through VCC Medical NV Partnership - EMCM is supporting the production of Reniale - a personalised treatment for renal cancer - in partnership with VCC Medical NV
EMCM Contributes to Renal Cancer Treatment through VCC Medical NV Partnership

 

NewswireToday - /newswire/ - Amsterdam, North Holland, Netherlands, 2015/08/28 - EMCM is supporting the production of Reniale - a personalised treatment for renal cancer - in partnership with VCC Medical NV.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

European Medical Contract Manufacturing BV (EMCM) recently renewed its partnership with VCC Medical NV to support the production of Reniale® - a personalised treatment for renal cancer. EMCM supports the production of Reniale® by aseptically processing cancer tissue from the patient’s tumour into a biological medicine, which stimulates the immune system to fight against residual cancer cells.

Developed by VCC Medical NV, Reniale® is capable of significantly prolonging a patient’s life by helping to prevent metastases after the removal of the kidney or parts thereof. EMCM (emcm.com) supports the production of this revolutionary cancer treatment by aseptically processing the tumours at its ISO and GMP accredited cleanroom facilities as per VCC Medical NV’s strict requirements.

“Choosing the right partner is of the utmost importance in the sensitive field of personalised medicine manufacturing. We are happy to have contracted EMCM, a well-established and reliable partner capable of meeting our specialised needs. With great confidence we are facing a fruitful future to reach the common aim, which is serving a well-tolerated treatment to patients with a life threatening disease,” said Dr. Rueggeberg, Delegate of the Supervisory Board of Vaccentis AG, the parent company and sole owner of VCC Medical NV.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Leader Biomedical

 
 

PREMIUM Article / Social Media:

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


EMCM Contributes to Renal Cancer Treatment through VCC Medical NV Partnership

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Werner Schoeman - LeaderBiomedical.com 
+31(0)20 799 7793 media[.]leaderbiomedical.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Leader Biomedical securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Leader Biomedical / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Leader Biomedical Group Enters APAC Market with New Offices in Malaysia
Leader Biomedical Launches Comprehensive Orthobiologics Portfolio
Leader Biomedical Group Partners with BioTiss Austria in New ECOO® Technology Venture
Leader Biomedical Group Establishes Operations in Brazil to Tap the Growing Biomaterials Market
Leader Biomedical Group Receives Approval to Distribute Bioresorbable Grafts in Switzerland
EMCM Contributes to Renal Cancer Treatment through VCC Medical NV Partnership
Leader Biomedical Group Opens Office in India

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)